| Sign In to gain access to subscriptions and/or personal tools. |
Should ethanol be scheduled as a drug of high risk to public health?
1 Professor of Psychiatry and Addiction Medicine, Director, National
Addiction Centre, University of Otago, Christchurch, PO Box 4345, Christchurch
Mail Centre, Christchurch 8140, New Zealand
* To whom correspondence should be addressed.
Abstract Six criteria described in the New Zealand Misuse of Drugs Act and used by the Expert
Advisory Committee on Drugs (EACD) for determining the risk of a drug to public
health were examined in relation to ethanol, using Key Words: alcohol, classification, drugs of abuse
First published on June 26, 2008, doi:10.1177/0269881108091596 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-hydroxybutyric acid
(GHB) as a comparator drug. GHB is an ideal candidate for use as a comparator
because it is a sedative substance very similar to ethanol and has been previously
investigated by the EACD using these six criteria. GHB was subsequently classified
as a Class B1 drug under the Misuse of Drugs Act, that is, as a prohibited drug of
high risk to public health. The dangerousness level of ethanol was found to be at
least similar to that of GHB in this analysis. This highlights a major discrepancy
in public policy.